Veradiag, a new diagnosis tool in rheumatoid arthritis Survey

1. What is your name? What is your position?

What is your name? What is your position?

2. What is the department/industry you are working for?

What is the department/industry you are working for? Healthcare system (hospitals, clinics, …)

Physician

Pharmaceutical/Biotech industry

University

Clinical center

Patient

Other

3. Are you working on Rheumatoid Arthritis or with Rheumatoid Arthritis patients?

Are you working on Rheumatoid Arthritis or with Rheumatoid Arthritis patients? Often

Sometimes

Rarely

Never

4. Which therapy/combined therapies are you using / prescribing? (multiple choices possible)

	Only	Infliximab (Remicade®)	Adalimumab (Humira®)	Golimumab (Simoni®)	Etanercept (Enbrel®)	Certolizumab (Cimzia®)	Other
Methotrexate	*Which therapy/combined therapies are you using / prescribing? (multiple choices possible) Methotrexate Only	Methotrexate Infliximab (Remicade®)	Methotrexate Adalimumab (Humira®)	Methotrexate Golimumab (Simoni®)	Methotrexate Etanercept (Enbrel®)	Methotrexate Certolizumab (Cimzia®)	Methotrexate Other
Sulfasalazine	Sulfasalazine Only	Sulfasalazine Infliximab (Remicade®)	Sulfasalazine Adalimumab (Humira®)	Sulfasalazine Golimumab (Simoni®)	Sulfasalazine Etanercept (Enbrel®)	Sulfasalazine Certolizumab (Cimzia®)	Sulfasalazine Other
Léflunomide	Léflunomide Only	Léflunomide Infliximab (Remicade®)	Léflunomide Adalimumab (Humira®)	Léflunomide Golimumab (Simoni®)	Léflunomide Etanercept (Enbrel®)	Léflunomide Certolizumab (Cimzia®)	Léflunomide Other
Only	Only Only	Only Infliximab (Remicade®)	Only Adalimumab (Humira®)	Only Golimumab (Simoni®)	Only Etanercept (Enbrel®)	Only Certolizumab (Cimzia®)	Only Other
Other(s)	Other(s) Only	Other(s) Infliximab (Remicade®)	Other(s) Adalimumab (Humira®)	Other(s) Golimumab (Simoni®)	Other(s) Etanercept (Enbrel®)	Other(s) Certolizumab (Cimzia®)	Other(s) Other

Other (please precise)

5. Which factors do you use to diagnose rheumatoid arthritis and / or follow the disease state?

	Always	Sometimes	Never
Rheumatoid factors	*Which factors do you use to diagnose rheumatoid arthritis and / or follow the disease state? Rheumatoid factors Always	Rheumatoid factors Sometimes	Rheumatoid factors Never
Anti-CCP2 Antibody test	Anti-CCP2 Antibody test Always	Anti-CCP2 Antibody test Sometimes	Anti-CCP2 Antibody test Never
Antinuclear antibody (ANA) test	Antinuclear antibody (ANA) test Always	Antinuclear antibody (ANA) test Sometimes	Antinuclear antibody (ANA) test Never
Anti-keratin antibody (AKA) test	Anti-keratin antibody (AKA) test Always	Anti-keratin antibody (AKA) test Sometimes	Anti-keratin antibody (AKA) test Never
Vectra DA	Vectra DA Always	Vectra DA Sometimes	Vectra DA Never
LISA Tracker	LISA Tracker Always	LISA Tracker Sometimes	LISA Tracker Never

Other (please precise)

6. To which purpose are you using it?

To which purpose are you using it? Diagnosis

Prognosis

Monitoring of the respons to a biotherapy

7. What are your criteria for choosing this /those test(s)?

What are your criteria for choosing this /those test(s)? Efficacy

Reliability

Predictability of the disease state

Price

Other

8. If an easy, reliable monitoring test based on the dosage of soluble VE-cadherin in serum would be available to predict the responsiveness to biotherapies and / or the disease state in Rheumatoid Arthritis patients, would you consider using it?
(http://onlinelibrary.wiley.com/doi/10.1002/art.33336/pdf)

If an easy, reliable monitoring test based on the dosage of soluble VE-cadherin in serum would be available to predict the responsiveness to biotherapies and / or the disease state in Rheumatoid Arthritis patients, would you consider using it? (http://onlinelibrary.wiley.com/doi/10.1002/art.33336/pdf) For sure

Yes

May be

Not at all

Other (please comment)

9. If this test would be also an indicator of atherosclerosis in Rheumatoid Arthritis patients, how would you consider this test?

If this test would be also an indicator of atherosclerosis in Rheumatoid Arthritis patients, how would you consider this test? Highly interesting

Interesting

Valuable

Not interesting

Other (please comment)

10. What is the main criteria you will look for using this new test?

What is the main criteria you will look for using this new test?